From the Editor

Law and Pharma

May 02, 2022

A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.

Dual Modality and New Analyses

May 02, 2022

Fresh insight is instrumental in the discussion of novel analytics.

A Future Investment

April 02, 2022

The AMR Action Fund has made its first investments, marking an important step forward for the partnership to achieve its goal of bringing new treatments to the market for priority pathogens.

Next Level Interrogation

April 02, 2022

3D cell cultures could provide key avenues to unlocking critical information.

Standing in Solidarity

March 02, 2022

As Russia’s invasion of Ukraine continues, industry leaders speak out in condemnation of the actions taking place and pledge to provide aid to those in need.

Characterizing the Unseen Drama of Analytics

March 02, 2022

Borrowing is good, but invention is best.

The Price Debate

February 02, 2022

As company revenues are gaining a boost from COVID-19, the issue of pricing is being debated once more.

Celebrate the New

February 02, 2022

The process of reshaping inevitably leads to fresh insights.

Hot Picks for 2022

January 02, 2022

Overall, 2021 proved to be another good year for drug approvals in Europe, albeit with a slight disappointment for Alzheimer’s patients, but what should industry be watching out for in 2022?

January Makes Your Head Spin

January 02, 2022

January is the kind of month that can make your head spin.